Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;23(7):822-827.
doi: 10.1111/odi.12606. Epub 2016 Dec 23.

Immune reconstitution inflammatory syndrome in HIV infection: taking the bad with the good

C-S Wong  1 , E S Richards  1 , L Pei  1 , I Sereti  1
Affiliations
Review

Immune reconstitution inflammatory syndrome in HIV infection: taking the bad with the good

C-S Wong et al. Oral Dis. 2017 Oct.

Abstract

In this review, we will describe the immunopathogies of immune reconstitution inflammatory syndrome, IRIS. IRIS occurs in a small subset of HIV patient, initiating combination antiretroviral therapy (ART), where immune reconstitution becomes dysregulated, resulting in an overly robust antigen-specific inflammatory reaction. We will discuss IRIS in terms of the associated coinfections: mycobacteria, cryptococci, and viruses.

Keywords: HIV; coinfection; immune reconstitution; immunology; lymphopenia; microbiology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Oral Kaposi sarcoma as an unmasking IRIS manifestation. Patient had no oral or skin lesions when starting ART with a CD4 count of 15 cells/μL and plasma HIV-RNA 121,410 copies/mL. After 4 weeks of ART, his CD4 count had increased to 77 cells/μL, HIV-RNA had dropped to 128 copies/mL and he had mucosal purple lesions typical of KS.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501. - PMC - PubMed
    1. Adams IB, Schafer JJ, Roberts AL, Short WR. Mycobacterium avium complex (MAC) Immune Reconstitution Syndrome (IRIS) With Reduced Susceptibility to Ethambutol in an HIV-Infected Patient. Ann Pharmacother. 2014;48:1219–1224. - PubMed
    1. Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol. 2015;6:1016. - PMC - PubMed
    1. Amogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A, Sonnerborg A, Aklillu E, Lindquist L. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/muL: TB-HAART Study, a Randomized Clinical Trial. PLoS One. 2015;10:e0122587. - PMC - PubMed
    1. Andrade BB, Hullsiek KH, Boulware DR, Rupert A, French MA, Ruxrungtham K, Montes ML, Price H, Barreiro P, Audsley J, Sher A, Lewin SR, Sereti I, Group IS. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013;207:1379–88. - PMC - PubMed

MeSH terms

Substances